PTPRC and colorectal carcinoma: Flow cytometry analysis further confirmed a significantly decreased percentage of MDSCs (defined as CD45+ CD11b+ F4/80− GR‐1+)[33] in C2–4 KO CRC tissues (Figure S8C,D, Supporting Information).